Preferred Name | Indinavir | |
Synonyms |
|
|
Definitions |
A synthetic hydroxyaminopentane amide agent that selectively inhibits the protease of both human immunodeficiency virus 1 and 2. The incorporation of a basic amine into the hydroxyethylene backbone improves its aqueous solubility and its oral bioavailability. |
|
ID |
http://purl.obolibrary.org/obo/NCIT_C66877 |
|
ALT_DEFINITION |
A drug that interferes with the ability of a virus to make copies of itself. |
|
CAS_Registry |
180683-37-8 |
|
Chemical_Formula |
C36H47N5O4.H2O |
|
code |
C66877 |
|
Contributing_Source |
FDA |
|
definition |
A synthetic hydroxyaminopentane amide agent that selectively inhibits the protease of both human immunodeficiency virus 1 and 2. The incorporation of a basic amine into the hydroxyethylene backbone improves its aqueous solubility and its oral bioavailability. |
|
FDA_UNII_Code |
5W6YA9PKKH |
|
Has_Salt_Form | ||
in_subset | ||
label |
Indinavir |
|
Legacy Concept Name |
Indinavir_Base |
|
Preferred_Name |
Indinavir |
|
prefixIRI |
NCIT:C66877 |
|
prefLabel |
Indinavir |
|
Semantic_Type |
Pharmacologic Substance |
|
UMLS_CUI |
C0376637 |
|
subClassOf |